MALAT1 achieves this by modulating multiple molecular pathways involved in DNA repair, apoptosis, and drug efflux, thus diminishing treatment efficacy and contributing to tumor recurrence and progression (Kim et al., 2018; Baspinar et al., 2020). Here, MALAT1 is linked to neoplasm.